Dividends and Buybacks

Dividends and Buybacks Articles

UBS reports that corporations are generating an incredible $1 trillion a year in cash, and the believe these five top companies will stay focused on returning capital to shareholders.
Most major companies seem to be raising their dividends year after year. That may be the case for most companies, but certainly not all.
Many investors will cheer the dividend and shareholder treatment comments from J.P. Morgan's investors day presentation by Jamie Dimon.
Health Care REIT has priced its underwritten public secondary offering of 17 million shares, but some investors may be wondering if it priced the offering too low.
We combined two Merrill Lunch ideas that secular contrarians should be long, or own now, and screened the firm's stocks universe for large-cap dividend yield stocks that are rated Buy.
If there was any segment that took a beating in 2014 in addition to the energy sector, it was the business development companies.
Wal-Mart reported better-than-expected fourth-quarter and fiscal year 2015 earnings before markets opened Thursday morning.
Even with costs being slashed and share buybacks being halted, it appears that investors who have already taken a hit with share prices dropping should continue to get their quarterly dividend checks.
Apple's market cap is now larger than those of General Electric, Wal-Mart, General Motors and McDonald's combined.
PepsiCo reported better-than-expected fourth-quarter and full-year 2014 results before markets opened Wednesday morning.
Credit Suisse that is still incredibly bullish on Boardwalk Pipeline Partners after its fourth-quarter earnings release.
Microsoft has filed with the SEC to raise additional capital via a debt offering to help fund share buybacks.
24/7 Wall St. screened the updated UBS Dividend Ruler list for five of the current highest yielding companies.
ThinkstockRetailers are scheduled to announce January U.S. same-store sales figures Thursday. Research firm Retail Metrics projected an overall gain of 3.1% year-over-year. In January of 2014, retail...
Gilead Sciences has become so large and accumulated enough capital that it has decided to begin paying a dividend, a move follows Amgen.